Need professional-grade analysis? Visit stockanalysis.com
$55.49M
N/A
N/A
N/A
BioMark Diagnostics Inc (BMKDF) trades on United States in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $0.42, up 1.22% from the previous close.
Over the past year, BMKDF has traded between a low of $0.17 and a high of $0.46. The stock has gained 135.4% over this period. It is currently 7.9% below its 52-week high.
BioMark Diagnostics Inc has a market capitalization of $55.49M.
Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer, as well as glioblastoma (GBM), breast cancer, and head and neck cancer. It is also developing liquid biopsy tests for various cancer types, including glioblastoma, gastrointestinal, prostate, head, neck cancers. The company was incorporated in 2014 and is headquartered in Richmond, Canada.
Side-by-side comparison against top Healthcare peers.